Curium plans $10M investment, 34 new jobs in Noblesville radiopharmaceutical facility
Curium, a nuclear medicine company with global headquarters in London and Paris and its North American headquarters in St. Louis, took over the Noblesville facility when it acquired Zevacor Molecular in March 2020.